1M+
3
60+
700
COVID-19 Research
More than one-fifth of Fred Hutch researchers have active projects related to COVID-19. Across the organization, scientists are tackling all aspects of the disease and the SARs-CoV-2 virus that causes it — including coordinating vaccine development, testing potential therapies, tracking how it spreads, how it affects our bodies and how to safely return to schools and offices.
Our Commitment
Fred Hutch is committed to becoming an anti-racist institution. In this endeavor, we are determined to strengthen and deepen our efforts that affirm the equal rights, value and protection of Black people and other minority communities — in the streets, on our campus and in our science.
This spring, we are assessing our progress toward our goals and will be reporting out in the coming months.
Meet Our Researchers
View All Faculty & Labs
Immunotherapy for Solid Tumors
Dr. Shivani Srivastava works to understand how immune cells called T cells normally find and attack diseased cells successfully, and how biological mechanisms underlying these functions can be manipulated by scientists to develop more effective genetically engineered T-cell therapies against solid tumors.
Targeted Lung Cancer Therapy
Targeted therapies have transformed outcomes for lung cancer patients. After reduced smoking rates, drugs that take aim at signature alterations in tumor cells are the main reason that the lung cancer death rate has dropped. Dr. Alice Berger is working to extend these advances to more patients with this malignancy.
Upcoming Events
Find More Events >Obliteride
Your search for "" did not match any of our events. Please try another event term or combination of terms and filters.
Help Us Eliminate Cancer
Every dollar counts. Please support lifesaving research today.